The eight identified parameters with significant differences, except for age, suggest that compared with astrocytomas, glioblastomas have a higher biological activity, characterized by their invasive and proliferative capacities; this indicates their malignant potential in the early stages, leading to a precise diagnosis of the IDH status. This evidence concerns the gene IDH2 and glioblastoma.